ALLIANCE/PFC SECURITY AGREEMENT
THIS ALLIANCE/PFC SECURITY AGREEMENT (this "Security Agreement") is made as of this 19th day of
May, 2000, by and between Alliance Pharmaceutical Corp., a New York corporation (the "Debtor"), and PFC
Therapeutics, LLC, a Delaware limited liability company (the "Secured Party").
1. OBLIGATIONS SECURED. The security interest granted by this Security Agreement shall secure
performance of all obligations and responsibilities of the Debtor (collectively the "Secured Obligations") arising
out of, connected with or related to Section 6.3(b)(i) of the Limited Liability Company Operating Agreement of
PFC Therapeutics, LLC dated as of May 17, 2000, between the Debtor and Baxter Healthcare Corporation
(the "Operating Agreement").
2. GRANT OF SECURITY INTEREST. The Debtor does hereby grant to the Secured Party a security interest
in the collateral described or referred to in Section 3 to secure the Secured Obligations.
3. COLLATERAL. Debtor's collateral subject to the security interest ("Collateral") shall consist of all right, title
and interest of the Debtor to and in the following:
(a) all Copyrights, Trade Secrets, Improvements, designs, drawings, plans, specifications, methods, systems,
clinical data, processes, practices compositions, techniques and other technical information or documentation,
whether patentable or not, solely owned by the Debtor, or which the Debtor has or obtains the right to control
the use of through a license or otherwise, relating to the Product, now or hereafter acquired (the "Know-How");
(b) all patents listed in Schedule A attached hereto or added thereto during the term of this Security Agreement;
(c) all patent applications listed in Schedule B attached hereto or added thereto during the term of this Security
Agreement, and any division, continuation, or continuation-in-part of any such application, and any patent which
shall issue based on such application, division, continuation or continuation-in-part;